Compare Nutanix Inc (NTNX) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nutanix Inc vs Summit Therapeutics Inc — how do they compare? Nutanix Inc trades at $53.61 (market cap $14.90B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Nutanix Inc is the larger of the two by market cap, and Nutanix Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| NTNX | SMMT | |
|---|---|---|
Market Cap | $14.90B | $10.48B |
Sector | Technology | Health |
52-Week High | $81.12 | $29.32 |
52-Week Low | $34.41 | $13.05 |
Enterprise Value | $14.41B | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
